These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4939734)

  • 21. Cranberry therapy for children's urinary tract infections.
    Kemper KJ
    Arch Pediatr Adolesc Med; 2006 Apr; 160(4):451-2. PubMed ID: 16585495
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transferable antibiotic resistance in Escherichia coli isolated from urinary-tract infections: hospital v. community patients.
    Rotimi VO; Emina PA; Eke PI
    Afr J Med Med Sci; 1984; 13(1-2):47-53. PubMed ID: 6087639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
    Honderlick P; Cahen P; Gravisse J; Vignon D
    Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental study of a new nitrofuran. 2-amino-4-methyl-6-(2-ethinyl-5-nitrofuryl)-pyrimidine].
    Castelli M; Genedani S; Viappiani A; Bertolini A
    G Ital Chemioter; 1978; 25(2):123-6. PubMed ID: 755791
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lower urinary tract infections: bacterial epidemiology and recommendations].
    Bergogne-Bérézin E
    Prog Urol; 2008 Feb; 18(1 Suppl FMC):F11-4. PubMed ID: 18773847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diclofenac in the management of E. coli urinary tract infections.
    Mazumdar K; Dutta NK; Dastidar SG; Motohashi N; Shirataki Y
    In Vivo; 2006; 20(5):613-9. PubMed ID: 17091768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Profile and sensitivity to antibiotics of 2063 uropathogenic bacteria isolated in the center of Tunisia].
    Boukadida J; Boukadida N; Elraii S
    Bull Soc Pathol Exot; 2002 Mar; 95(1):8-10. PubMed ID: 12012968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary tract infections in the elderly.
    Richardson JP
    Md Med J; 1995 Sep; 44(9):703-4. PubMed ID: 7564928
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibiotic therapy in urinary tract infections from the clinician's viewpoint].
    Straube W
    Z Allgemeinmed; 1972 Apr; 48(10):479-80. PubMed ID: 5033209
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
    Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
    J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997.
    Dyer IE; Sankary TM; Dawson JA
    West J Med; 1998 Nov; 169(5):265-8. PubMed ID: 9830353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change in the resistance of colienteritis pathogens to antibiotics and nitrofuran preparation in Dnepropetrovsk, 1956-1962].
    KOVALENKO AD
    Antibiotiki; 1963 Mar; 8():283-7. PubMed ID: 14035186
    [No Abstract]   [Full Text] [Related]  

  • 34. Pivmecillinam in uncomplicated urinary tract infections in general practice.
    Peddie BA; Little PJ
    N Z Med J; 1981 Feb; 93(678):109-11. PubMed ID: 6267530
    [No Abstract]   [Full Text] [Related]  

  • 35. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

  • 36. [The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].
    Drulis-Kawa Z; Weber-Dabrowska B; Lewczyk E; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2002 Dec; 13(78):470-2. PubMed ID: 12666443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluoroquinolone resistance of human pathogenic bacteria. Resistant E coli now appearing in Sweden].
    Osterlund A; Olsson-Liljequist B
    Lakartidningen; 1999 Apr; 96(16):1965-6. PubMed ID: 10330864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli.
    Balagué C; Stürtz N; Rey R; De Ruiz CS; Nader-Macías ME; Duffard R; De Duffard AM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):337-46. PubMed ID: 17034416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hospitalism in urology].
    Lipsky H
    Med Klin; 1970 Oct; 65(42):1833-8. PubMed ID: 4997048
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazino-acethydrazone, a new hydrosoluble nitrofuran derivative. Studies on in vivo chemotherapeutic activity.
    Degen L; Salvaterra M; Vella S; Pesatori M
    Chemotherapy; 1973; 18(2):85-90. PubMed ID: 4564391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.